To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Speech in Commons Chamber - Mon 19 Jan 2026
Oral Answers to Questions

"The Secretary of State told the House that the guidance for schools would be published by the end of 2025, yet here we still are without the guidance anywhere to be seen. There is immense pressure on schools, colleges, children’s homes and other settings to socially transition children, often irrespective …..."
Rosie Duffield - View Speech

View all Rosie Duffield (Ind - Canterbury) contributions to the debate on: Oral Answers to Questions

Speech in Commons Chamber - Mon 19 Jan 2026
Oral Answers to Questions

"12. What recent progress she has made on publishing guidance for gender-questioning children in schools. ..."
Rosie Duffield - View Speech

View all Rosie Duffield (Ind - Canterbury) contributions to the debate on: Oral Answers to Questions

Division Vote (Commons)
14 Jan 2026 - Public Order - View Vote Context
Rosie Duffield (Ind) voted No and against the House
One of 8 Independent No votes vs 1 Independent Aye votes
Vote Tally: Ayes - 301 Noes - 110
Speech in Commons Chamber - Tue 13 Jan 2026
Oral Answers to Questions

"The United States Department of Health and Human Services’ peer-reviewed report found that harms from paediatric medical transition are significant, long term and too often ignored and inadequately tracked, as testified by Keira Bell, who is here in Parliament today. What is the Government’s rationale behind medicalising yet more vulnerable …..."
Rosie Duffield - View Speech

View all Rosie Duffield (Ind - Canterbury) contributions to the debate on: Oral Answers to Questions

Speech in Commons Chamber - Tue 13 Jan 2026
Oral Answers to Questions

"3. What discussions he has had with King’s College London on the compliance of the PATHWAYS puberty blocker trial with the Medicines for Human Use (Clinical Trials) Regulations 2004. ..."
Rosie Duffield - View Speech

View all Rosie Duffield (Ind - Canterbury) contributions to the debate on: Oral Answers to Questions

Division Vote (Commons)
12 Jan 2026 - Finance (No. 2) Bill - View Vote Context
Rosie Duffield (Ind) voted No and against the House
One of 5 Independent No votes vs 4 Independent Aye votes
Vote Tally: Ayes - 324 Noes - 180
Division Vote (Commons)
12 Jan 2026 - Finance (No. 2) Bill - View Vote Context
Rosie Duffield (Ind) voted Aye and against the House
One of 2 Independent Aye votes vs 6 Independent No votes
Vote Tally: Ayes - 167 Noes - 350
Division Vote (Commons)
12 Jan 2026 - Finance (No. 2) Bill - View Vote Context
Rosie Duffield (Ind) voted Aye and against the House
One of 3 Independent Aye votes vs 5 Independent No votes
Vote Tally: Ayes - 188 Noes - 341
Division Vote (Commons)
12 Jan 2026 - Finance (No. 2) Bill - View Vote Context
Rosie Duffield (Ind) voted Aye and against the House
One of 4 Independent Aye votes vs 5 Independent No votes
Vote Tally: Ayes - 185 Noes - 344
Division Vote (Commons)
12 Jan 2026 - Finance (No. 2) Bill - View Vote Context
Rosie Duffield (Ind) voted No and against the House
One of 3 Independent No votes vs 5 Independent Aye votes
Vote Tally: Ayes - 344 Noes - 181